Nuno Miguel Gomes Andrade

Title: Nuno Miguel Gomes Andrade: Innovator in Neuroprotective Therapies

Introduction

Nuno Miguel Gomes Andrade is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of therapeutic proteins, particularly focusing on neuroprotective treatments. With a total of four patents to his name, Andrade is recognized for his innovative approaches to addressing disorders of the nervous system.

Latest Patents

Andrade's latest patents include the therapeutic use of a growth factor known as METRNL. This invention relates to the application of proteins, genes, and cells in therapy, specifically targeting the biological function of METRNL. This secreted therapeutic protein serves as a Nerve Survival and Growth factor, exhibiting neuroprotective and neurogenesis effects. The focus of his work is on developing treatments for various nervous system disorders.

Career Highlights

Throughout his career, Andrade has worked with notable companies such as Hoba Therapeutics ApS and Nsgenee A/S. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.

Collaborations

Andrade has collaborated with esteemed colleagues, including Lone Fjord-Larsen and Lars Ulrik Wahlberg. These partnerships have further enriched his research and development efforts in the field of neuroprotective therapies.

Conclusion

Nuno Miguel Gomes Andrade stands out as a key figure in the innovation of therapeutic proteins for nervous system disorders. His work with METRNL and collaborations with industry professionals highlight his commitment to advancing medical science.